Merrimack Pharmaceuticals, Inc. Gains 212.75%
Wed, Nov 09, 2022 at 07:52 PM
Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ) soared at $12.51, a gain of 212.8%. On Wed, Nov 09, 2022, MACK:NASDAQ hit a New 2-Week High of $12.51. The stock appeared on our News Catalysts scanner on Wed, Nov 09, 2022 at 12:30 PM in the 'BIOTECH' category. From Wed, Oct 26, 2022, the stock recorded 80.00% Up Days and 36.36% Green Days
About Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ)
Merrimack Pharmaceuticals Inc is a biotechnology company. It discovers, develops, and commercializes innovative medicines consisting of novel therapeutics paired with diagnostics to treat various types of cancer.
Top 10 Gainers:
- Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ), 212.75%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Outset Medical Inc. (OM:NASDAQ), 29.9%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 29.6%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Riskified Ltd. Class A (RSKD:NYSE), 24.94%
- Health Catalyst, Inc. (HCAT:NASDAQ), 23.34%
- Quotient Technology Inc. (QUOT:NYSE), 22.81%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 22.8%
- Vivint Smart Home, Inc. (VVNT:NYSE), 20.57%